Steven E. Finkelstein

8.5k total citations · 5 hit papers
71 papers, 6.6k citations indexed

About

Steven E. Finkelstein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Steven E. Finkelstein has authored 71 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 27 papers in Immunology. Recurrent topics in Steven E. Finkelstein's work include Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (12 papers). Steven E. Finkelstein is often cited by papers focused on Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (12 papers). Steven E. Finkelstein collaborates with scholars based in United States, Canada and United Kingdom. Steven E. Finkelstein's co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Christopher A. Klebanoff, Douglas C. Palmer, Paul A. Antony, Luca Gattinoni, Paul J. Spiess, Deborah R. Surman, Leroy N. Hwang and Zhiya Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Steven E. Finkelstein

70 papers receiving 6.5k citations

Hit Papers

Removal of homeostatic cytokine sinks by lymphodepletion ... 2003 2026 2010 2018 2005 2005 2003 2005 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells
    2005 812 citations Luca Gattinoni, Steven E. Finkelstein et al. The Journal of Experimental Medicine profile →
  2. Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells
    2005 752 citations Christopher A. Klebanoff, Luca Gattinoni et al. Proceedings of the National Academy of Sciences profile →
  3. Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
    2003 751 citations Willem W. Overwijk, Marc R. Theoret et al. The Journal of Experimental Medicine profile →
  4. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
    2005 592 citations Rong Zeng, Rosanne Spolski et al. The Journal of Experimental Medicine profile →
  5. CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells
    2005 585 citations Paul A. Antony, Ciriaco A. Piccirillo et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. Finkelstein United States 32 4.1k 4.0k 998 982 772 71 6.6k
Colleen Simpson United States 14 4.2k 1.0× 3.8k 0.9× 766 0.8× 1.2k 1.3× 699 0.9× 19 7.0k
Thomas E. Darga United States 25 2.5k 0.6× 3.1k 0.8× 1.2k 1.2× 1.6k 1.7× 210 0.3× 34 5.4k
Byron Burnette United States 14 3.2k 0.8× 3.9k 1.0× 1.3k 1.3× 984 1.0× 114 0.1× 15 5.8k
Michael R. Verneris United States 54 6.5k 1.6× 4.1k 1.0× 391 0.4× 1.5k 1.5× 559 0.7× 254 10.7k
Liufu Deng China 22 4.5k 1.1× 4.0k 1.0× 1.2k 1.2× 1.8k 1.8× 149 0.2× 34 7.3k
Marka R. Crittenden United States 37 2.4k 0.6× 2.8k 0.7× 583 0.6× 719 0.7× 212 0.3× 106 4.0k
Kwong Y. Tsang United States 38 3.5k 0.9× 3.1k 0.8× 818 0.8× 1.5k 1.5× 529 0.7× 109 5.2k
James W. Hodge United States 61 7.9k 2.0× 7.8k 1.9× 2.5k 2.5× 2.7k 2.8× 1.1k 1.5× 196 12.3k
Samir N. Khleif United States 39 1.9k 0.5× 3.0k 0.7× 731 0.7× 1.2k 1.3× 301 0.4× 114 4.6k
Ainhoa Arina United States 28 2.7k 0.7× 2.3k 0.6× 486 0.5× 1.1k 1.1× 235 0.3× 50 4.2k

Countries citing papers authored by Steven E. Finkelstein

Since Specialization
Citations

This map shows the geographic impact of Steven E. Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Finkelstein more than expected).

Fields of papers citing papers by Steven E. Finkelstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Finkelstein. The network helps show where Steven E. Finkelstein may publish in the future.

Co-authorship network of co-authors of Steven E. Finkelstein

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Finkelstein. A scholar is included among the top collaborators of Steven E. Finkelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Finkelstein. Steven E. Finkelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heysek, Randy V., et al.. (2024). Image-Guided Superficial Radiation Therapy for Basal and Squamous Cell Carcinomas Produces Excellent Freedom from Recurrence Independent of Risk Factors. Journal of Clinical Medicine. 13(19). 5835–5835. 1 indexed citations
2.
Cheuvront, Samuel N., et al.. (2020). Alleviation of Cancer Therapy-Induced Gastrointestinal Toxicity using an Amino Acid Medical Food. 3 indexed citations
3.
Poleszczuk, Jan, Kimberly A. Luddy, Mark Robertson‐Tessi, et al.. (2016). Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions. Cancer Research. 76(5). 1009–1018. 92 indexed citations
4.
Yashar, Catheryn M., Deanna J. Attai, E. Brian Butler, et al.. (2016). Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study. Brachytherapy. 15(6). 780–787. 21 indexed citations
5.
Parker, Christopher, Steven E. Finkelstein, Jeff M. Michalski, et al.. (2016). Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial. European Urology. 70(5). 875–883. 51 indexed citations
6.
Seebauer, Christian, Matthias Schuster, Thomas von Woedtke, et al.. (2015). Head and neck cancer treatment and physical plasma. 3(1). 17–23. 167 indexed citations
7.
Liu, Jennifer, Steven E. Finkelstein, & Fritz François. (2015). Annual Fecal Occult Blood Testing can be Safely Suspended for up to 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients. The American Journal of Gastroenterology. 110(9). 1355–1358. 9 indexed citations
8.
Kupelian, Patrick A., et al.. (2014). Stereotactic body radiation therapy for prostate cancer: Rational and reasonable. Practical Radiation Oncology. 5(3). 188–192. 9 indexed citations
9.
Jabbour, Salma K., Sameh Hashem, Walter Bosch, et al.. (2013). Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus. Practical Radiation Oncology. 4(2). 82–89. 94 indexed citations
10.
Finkelstein, Steven E. & Mayer Fishman. (2012). Clinical opportunities in combining immunotherapy with radiation therapy. SHILAP Revista de lepidopterología. 2. 169–169. 33 indexed citations
11.
Klebanoff, Christopher A., Luca Gattinoni, Douglas C. Palmer, et al.. (2011). Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice. Clinical Cancer Research. 17(16). 5343–5352. 225 indexed citations
12.
Finkelstein, Steven E., Cristina Iclozan, Marilyn M. Bui, et al.. (2011). Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients. International Journal of Radiation Oncology*Biology*Physics. 82(2). 924–932. 101 indexed citations
13.
Seam, Nitin, et al.. (2007). The Workup of Stridor: Virtual Bronchoscopy as a Complementary Technique in the Diagnosis of Subglottic Stenosis. Respiratory Care. 52(3). 337–339. 4 indexed citations
14.
Kakinuma, Takashi, Hari Nadiminti, Anke S. Lonsdorf, et al.. (2006). Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location. Cancer Immunology Immunotherapy. 56(7). 1119–1131. 12 indexed citations
15.
Zeng, Rong, Rosanne Spolski, Steven E. Finkelstein, et al.. (2005). Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. The Journal of Experimental Medicine. 201(1). 139–148. 592 indexed citations breakdown →
16.
Gattinoni, Luca, Steven E. Finkelstein, Christopher A. Klebanoff, et al.. (2005). Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells. The Journal of Experimental Medicine. 202(7). 907–912. 812 indexed citations breakdown →
17.
Antony, Paul A., Ciriaco A. Piccirillo, Akgül Akpınarlı, et al.. (2005). CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells. The Journal of Immunology. 174(5). 2591–2601. 585 indexed citations breakdown →
18.
Klebanoff, Christopher A., Steven E. Finkelstein, Deborah R. Surman, et al.. (2004). IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells. Proceedings of the National Academy of Sciences. 101(7). 1969–1974. 481 indexed citations
19.
Finkelstein, Steven E., Ronald M. Summers, Dao M. Nguyen, & David S. Schrump. (2004). Virtual bronchoscopy for evaluation of airway disease. Thoracic surgery clinics/Thorac. surg. clin.. 14(1). 79–86. 21 indexed citations
20.
Khanna, Ramesh, et al.. (1982). MANAGEMENT OF END-STAGE SCLERODERMA RENAL DISEASE WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS - REPORT OF TWO CASES. Peritoneal Dialysis International. 2(4). 174–177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colleen Simpson Breakdown of academic impact, for papers by Thomas E. Darga Breakdown of academic impact, for papers by Byron Burnette Breakdown of academic impact, for papers by Michael R. Verneris Breakdown of academic impact, for papers by Liufu Deng Breakdown of academic impact, for papers by Marka R. Crittenden Breakdown of academic impact, for papers by Kwong Y. Tsang Breakdown of academic impact, for papers by James W. Hodge Breakdown of academic impact, for papers by Samir N. Khleif Breakdown of academic impact, for papers by Ainhoa Arina
Rankless by CCL
2026